All 157 XBI (STATE STREET(R) SPDR(R) S&P(R) BIOTECH ETF) Holdings
There are 157 XBI holdings. Top 10 companies weight: 13.61%.
Total Market Cap: $1.70T
Rank | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Average | (157 stocks) | +9.95% | 31.39 | 16.62 | 0.44 | +21.40% | +14.06% | 0.66 | ||||||||||
51 | ARWR | Arrowhead Pharmaceuticals Inc | 0.97% | $71.65 | $10B | Biotechnology | Healthcare | +15.23% | N/A | 111.11 | N/A | N/A | N/A | 78 | +33.98% | $96 | +1.03% | 1.63 |
52 | BIIB | Biogen Inc | 0.97% | $199.95 | $29B | Drug Manufacturers - General | Healthcare | -15.32% | 17.41 | 14.75 | 0.64 | N/A | N/A | 65 | +13.17% | $226 | -9.14% | 0.51 |
53 | DYN | Dyne Therapeutics Inc Ordinary Shares | 0.96% | $23.45 | $3.96B | Biotechnology | Healthcare | N/A | N/A | N/A | 0.19 | N/A | N/A | 76 | +67.16% | $39 | +3.77% | 1.77 |
54 | NUVL | Nuvalent Inc Class A | 0.95% | $123.96 | $9.75B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 50 | +0.03% | $124 | 0.00% | 0.97 |
55 | QURE | Uniqure Nv | 0.94% | $39.70 | $2.58B | Biotechnology | Healthcare | +2.11% | N/A | 27.93 | N/A | N/A | N/A | 75 | +63.40% | $65 | +7.92% | 0.98 |
56 | UTHR | United Therapeutics Corp | 0.93% | $529.34 | $22B | Drug Manufacturers - Specialty & Generic | Healthcare | +26.56% | 17.96 | 19.49 | 1.91 | N/A | N/A | 75 | +25.34% | $663 | +23.70% | 0.41 |
57 | IBRX | Immunitybio Inc Ordinary Shares | 0.93% | $7.50 | $8.10B | Biotechnology | Healthcare | -9.78% | N/A | N/A | N/A | N/A | N/A | 83 | +73.45% | $13 | -8.69% | 1.56 |
58 | ALNY | Alnylam Pharmaceuticals Inc | 0.92% | $272.67 | $37B | Biotechnology | Healthcare | N/A | 117.96 | 30.49 | 0.52 | N/A | N/A | 74 | +59.47% | $435 | +8.65% | 0.81 |
59 | BCRX | Biocryst Pharmaceuticals Inc | 0.87% | $9.11 | $2.39B | Drug Manufacturers - Specialty & Generic | Healthcare | +6.24% | N/A | 86.96 | N/A | N/A | N/A | 82 | +130.52% | $21 | -11.23% | 0.77 |
60 | VCYT | Veracyte Inc | 0.85% | $57.26 | $4.75B | Diagnostics & Research | Healthcare | N/A | 53.71 | 34.36 | 0.34 | N/A | N/A | 70 | -1.24% | $57 | +8.04% | 1.36 |
61 | TNGX | Tango Therapeutics Inc | 0.84% | $27.54 | $4.36B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +60.97% | $44 | +21.35% | 1.39 |
62 | IDYA | Ideaya Biosciences Inc | 0.82% | $35.45 | $3.23B | Biotechnology | Healthcare | +8.12% | N/A | 4.65 | N/A | N/A | N/A | 76 | +47.50% | $52 | +10.45% | 1.10 |
63 | SNDX | Syndax Pharmaceuticals Inc | 0.80% | $22.29 | $2.08B | Biotechnology | Healthcare | +12.13% | N/A | N/A | N/A | N/A | N/A | 78 | +74.97% | $39 | +7.89% | 1.03 |
64 | ARQT | N/A | 0.78% | $27.53 | $3.47B | Biotechnology | Healthcare | -58.89% | N/A | 158.73 | N/A | N/A | N/A | 78 | +25.75% | $35 | +0.98% | 1.24 |
65 | AGIO | Agios Pharmaceuticals Inc | 0.77% | $40.06 | $2.37B | Biotechnology | Healthcare | N/A | N/A | 2.47 | N/A | N/A | N/A | 67 | +6.39% | $43 | -6.30% | 1.02 |
66 | DNLI | Denali Therapeutics Inc | 0.77% | $22.90 | $3.65B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +49.56% | $34 | -18.93% | 1.45 |
67 | CLDX | Celldex Therapeutics Inc | 0.75% | $35.42 | $2.55B | Biotechnology | Healthcare | +21.48% | N/A | N/A | N/A | N/A | N/A | 76 | +62.42% | $58 | -3.94% | 1.17 |
68 | SRPT | Sarepta Therapeutics Inc | 0.75% | $16.83 | $1.86B | Biotechnology | Healthcare | N/A | 4.88 | 5.01 | 159.25 | N/A | N/A | 48 | +31.73% | $22 | -24.47% | 1.40 |
69 | MLYS | Mineralys Therapeutics Inc | 0.74% | $26.71 | $2.43B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 72 | +83.45% | $49 | 0.00% | 0.76 |
70 | NTLA | Intellia Therapeutics Inc | 0.72% | $10.92 | $1.57B | Biotechnology | Healthcare | +8.10% | N/A | N/A | N/A | N/A | N/A | 62 | +139.65% | $26 | -41.00% | 1.77 |
71 | VRDN | Viridian Therapeutics Inc | 0.72% | $18.56 | $1.95B | Biotechnology | Healthcare | -32.36% | N/A | 1.01 | N/A | N/A | N/A | 79 | +94.61% | $36 | +1.88% | 1.08 |
72 | IONS | Ionis Pharmaceuticals Inc | 0.71% | $52.95 | $9.08B | Biotechnology | Healthcare | -21.44% | N/A | 90.91 | N/A | N/A | N/A | 79 | +75.54% | $93 | +7.60% | 0.65 |
73 | RXRX | Recursion Pharmaceuticals Inc Class A | 0.70% | $2.89 | $1.76B | Biotechnology | Healthcare | -10.03% | N/A | N/A | N/A | N/A | N/A | 65 | +150.87% | $7.25 | -39.61% | 2.62 |
74 | IRON | Disc Medicine Inc Ordinary Shares | 0.70% | $74.38 | $2.90B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +36.53% | $102 | +6.97% | 1.15 |
75 | RCUS | Arcus Biosciences Inc | 0.70% | $28.17 | $3.52B | Biotechnology | Healthcare | +14.36% | N/A | N/A | N/A | N/A | N/A | 68 | +26.91% | $36 | -2.35% | 1.50 |
76 | IMNM | Immunome Inc Ordinary Shares | 0.66% | $22.16 | $2.59B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 80 | +61.42% | $36 | +4.86% | 1.64 |
77 | IOVA | Iovance Biotherapeutics Inc | 0.66% | $5.02 | $2.08B | Biotechnology | Healthcare | -12.60% | N/A | N/A | N/A | N/A | N/A | 75 | +75.30% | $8.80 | -26.70% | 1.59 |
78 | ADMA | Adma Biologics Inc | 0.65% | $8.75 | $2.02B | Biotechnology | Healthcare | N/A | 12.42 | 10.50 | N/A | N/A | N/A | 75 | +94.29% | $17 | +40.64% | 1.16 |
79 | KOD | Kodiak Sciences Inc | 0.61% | $40.87 | $2.64B | Biotechnology | Healthcare | +4.23% | N/A | N/A | N/A | N/A | N/A | 78 | +53.34% | $63 | -14.24% | 1.68 |
80 | NVAX | Novavax Inc | 0.61% | $7.88 | $1.39B | Biotechnology | Healthcare | -42.97% | N/A | 2.59 | 1.32 | N/A | N/A | 50 | +79.06% | $14 | -48.15% | 1.45 |
81 | PVLA | Palvella Therapeutics Inc | 0.60% | $124.15 | $2.18B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 75 | +84.94% | $230 | 0.00% | 1.01 |
82 | NRIX | Nurix Therapeutics Inc Ordinary Shares | 0.56% | $22.71 | $2.47B | Biotechnology | Healthcare | +10.31% | N/A | N/A | N/A | N/A | N/A | 81 | +43.11% | $33 | -5.48% | 1.36 |
83 | BHVN | Biohaven Ltd | 0.54% | $14.84 | $2.24B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +53.30% | $23 | 0.00% | 1.45 |
84 | VCEL | Vericel Corp | 0.54% | $45.88 | $2.38B | Biotechnology | Healthcare | +35.66% | 109.92 | 98.04 | 0.18 | N/A | N/A | 71 | +24.54% | $57 | -3.35% | 1.13 |
85 | ABSI | Absci Corp | 0.49% | $8.16 | $1.49B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +68.87% | $14 | 0.00% | 2.33 |
86 | GLUE | Monte Rosa Therapeutics Inc | 0.48% | $23.48 | $1.97B | Biotechnology | Healthcare | N/A | N/A | 10.02 | N/A | N/A | N/A | 81 | +41.27% | $33 | +1.58% | 1.31 |
87 | VIR | Vir Biotechnology Inc | 0.46% | $9.23 | $1.55B | Biotechnology | Healthcare | -0.01% | N/A | 4.27 | N/A | N/A | N/A | 82 | +133.59% | $22 | -24.33% | 1.52 |
88 | PURR | Hyperliquid Strategies Inc | 0.46% | $7.05 | $1.15B | Capital Markets | Financial Services | N/A | N/A | N/A | N/A | N/A | N/A | 83 | +85.11% | $13 | 0.00% | 3.37 |
89 | STOK | Stoke Therapeutics Inc | 0.45% | $27.68 | $1.86B | Biotechnology | Healthcare | +11.95% | N/A | 204.08 | N/A | N/A | N/A | 77 | +65.53% | $46 | -3.27% | 1.04 |
90 | TYRA | Tyra Biosciences Inc | 0.43% | $31.06 | $1.93B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 76 | +67.35% | $52 | 0.00% | 1.01 |
91 | CAPR | Capricor Therapeutics Inc | 0.43% | $19.50 | $1.17B | Biotechnology | Healthcare | +22.65% | N/A | 78.74 | N/A | N/A | N/A | 80 | +174.87% | $54 | +31.39% | 1.45 |
92 | CRVS | Corvus Pharmaceuticals Inc | 0.42% | $14.10 | $1.25B | Biotechnology | Healthcare | +53.96% | N/A | N/A | N/A | N/A | N/A | 78 | +136.38% | $33 | +43.22% | 0.75 |
93 | ANAB | Anaptysbio Inc | 0.42% | $50.29 | $1.62B | Biotechnology | Healthcare | -4.15% | N/A | N/A | N/A | N/A | N/A | 81 | +73.18% | $87 | +23.70% | 0.80 |
94 | CGEM | Cullinan Therapeutics Inc | 0.41% | $17.50 | $1.10B | Biotechnology | Healthcare | N/A | N/A | 6.74 | N/A | N/A | N/A | 77 | +80.29% | $32 | -8.28% | 1.05 |
95 | ANNX | Annexon Inc Ordinary Shares | 0.39% | $5.57 | $1.26B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 77 | +167.15% | $15 | -24.53% | 1.23 |
96 | ZBIO | Zenas Biopharma Inc | 0.38% | $30.70 | $1.83B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 71 | +37.20% | $42 | 0.00% | 1.24 |
97 | ARDX | Ardelyx Inc | 0.38% | $5.09 | $1.31B | Biotechnology | Healthcare | -26.76% | N/A | 40.65 | N/A | N/A | N/A | 77 | +220.24% | $16 | +21.47% | 0.79 |
98 | AVTX | Avalo Therapeutics Inc | 0.36% | $18.21 | $404M | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 78 | +145.41% | $45 | -70.96% | 0.53 |
99 | PGEN | Precigen Inc | 0.35% | $5.07 | $1.82B | Biotechnology | Healthcare | -3.91% | N/A | 250.00 | N/A | N/A | N/A | 75 | +145.56% | $12 | -2.38% | 1.66 |
100 | INBX | Inhibrx Biosciences Inc | 0.35% | $84.09 | $1.33B | Biotechnology | Healthcare | N/A | N/A | N/A | N/A | N/A | N/A | 66 | +230.00% | $278 | 0.00% | 1.39 |
XBI (STATE STREET(R) SPDR(R) S&P(R) BIOTECH ETF) Sector Allocation
HEALTHCARE
96.60%INFORMATION TECHNOLOGY
0.00%COMMUNICATION SERVICES
0.00%CONSUMER DISCRETIONARY
0.00%CONSUMER STAPLES
0.00%INDUSTRIALS
0.00%MATERIALS
0.00%UTILITIES
0.00%ENERGY
0.00%FINANCIALS
0.00%REAL ESTATE
0.00%